• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Intercapillary distance in the proliferating area of human glioma.

作者信息

Yoshii Y, Sugiyama K

机构信息

Department of Neurological Surgery, University of Tsukuba, Ibaraki, Japan.

出版信息

Cancer Res. 1988 May 15;48(10):2938-41.

PMID:3359450
Abstract

Tissues from 22 patients with glioma and 7 patients with normal white matter were used in this study. First we determined the proliferating area in the tumor tissue by evaluating the growth fraction (GF). Second we determined the mean number of cells and measured the intercapillary distance in a modified tumor cord in the proliferating area by using the texture analyzing system and Voronoi's method. Average GFs of tumor cells and tumor endothelial cells were 27.7 +/- 5.3% (SD) and 36.8 +/- 8.1% in many malignant gliomas and 6.5 +/- 3.1% and 17.0 +/- 11.9% in many benign gliomas. The mean number of cells within a tumor cord was 15.9 +/- 6.4 in the proliferating areas of all gliomas and 22.3 +/- 6.8 in the control group. The mean intercapillary distances were 77.8 +/- 15.9 micron in the proliferating area of all gliomas and 123 +/- 4.2 micron in the control group. There were significant differences in the number of cells and the intercapillary distances between the proliferating group and the control group (t value; P less than 0.05--less than 0.001). It has been suggested that GF is high in glioma cells and tumor endothelial cells in malignant gliomas and that GF of endothelial cells is always greater than that of the tumor cells. It is suggested that it is possible to use Voronoi's method for the interpretation of biological action in human gliomas.

摘要

相似文献

1
Intercapillary distance in the proliferating area of human glioma.
Cancer Res. 1988 May 15;48(10):2938-41.
2
Increased levels of tissue endostatin in human malignant gliomas.人类恶性胶质瘤中组织内皮抑素水平升高。
Clin Cancer Res. 2002 Sep;8(9):2933-8.
3
Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.分散因子/肝细胞生长因子基因转移在体内增强胶质瘤生长和血管生成。
Lab Invest. 1997 Apr;76(4):565-77.
4
[Ultrastructure of glioma vessel--morphometric study for proliferative potential of endothelial cell].[胶质瘤血管的超微结构——内皮细胞增殖潜能的形态计量学研究]
No To Shinkei. 1991 Feb;43(2):145-52.
5
AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activities, blocks the growth of malignant glioma.AAL881是一种新型小分子抑制剂,可抑制RAF和血管内皮生长因子受体的活性,阻断恶性胶质瘤的生长。
Cancer Res. 2006 Sep 1;66(17):8722-30. doi: 10.1158/0008-5472.CAN-06-0284.
6
Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1.用单克隆抗体MIB-1测定胶质瘤细胞和血管成分的增殖潜能。
J Exp Clin Cancer Res. 1997 Jun;16(2):153-7.
7
Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.血管生成素-2在人胶质瘤细胞中的表达及其在血管生成中的作用。
Cancer Res. 2001 Aug 15;61(16):6248-54.
8
Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1.
J Exp Clin Cancer Res. 1997 Dec;16(4):389-94.
9
Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.新型合成基质金属蛋白酶抑制剂AG3340在恶性胶质瘤肿瘤模型中对肿瘤生长有显著抑制作用。
Clin Cancer Res. 1999 Apr;5(4):845-54.
10
[Ultrastructure of glioma vessel--morphometric study for vascular permeability].[胶质瘤血管的超微结构——血管通透性的形态计量学研究]
No To Shinkei. 1991 Jan;43(1):49-56.

引用本文的文献

1
Self-organization of vascularized skeletal muscle from bovine embryonic stem cells.源自牛胚胎干细胞的血管化骨骼肌的自组织
bioRxiv. 2024 Mar 25:2024.03.22.586252. doi: 10.1101/2024.03.22.586252.
2
Mechanistically Weighted Metric to Predict In Vivo Antibody-Receptor Occupancy: An Analytical Approach.预测体内抗体-受体占有率的机制加权度量:一种分析方法。
J Pharmacol Exp Ther. 2023 Oct;387(1):78-91. doi: 10.1124/jpet.122.001540. Epub 2023 Apr 27.
3
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy.
利用计算引导的联合疗法克服BRAF抑制剂在肿瘤中的不同渗透情况。
Sci Adv. 2022 Apr 29;8(17):eabl6339. doi: 10.1126/sciadv.abl6339.
4
Enhancing carrier flux for efficient drug delivery in cancer tissues.提高载体通量以提高癌症组织中的药物递送效率。
Biophys J. 2021 Dec 7;120(23):5255-5266. doi: 10.1016/j.bpj.2021.10.036. Epub 2021 Oct 30.
5
Overview on the Different Patterns of Tumor Vascularization.肿瘤血管生成的不同模式概述。
Cells. 2021 Mar 13;10(3):639. doi: 10.3390/cells10030639.
6
Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.用于增强光动力和缺氧激活治疗联合抗癌活性的肿瘤穿透纳米粒子。
ACS Nano. 2017 Feb 28;11(2):2227-2238. doi: 10.1021/acsnano.6b08731. Epub 2017 Feb 6.
7
Cancer nanomedicine: progress, challenges and opportunities.癌症纳米医学:进展、挑战与机遇。
Nat Rev Cancer. 2017 Jan;17(1):20-37. doi: 10.1038/nrc.2016.108. Epub 2016 Nov 11.
8
Diffusion and Uptake of Tobacco Mosaic Virus as Therapeutic Carrier in Tumor Tissue: Effect of Nanoparticle Aspect Ratio.烟草花叶病毒作为肿瘤组织治疗载体的扩散与摄取:纳米颗粒纵横比的影响
J Phys Chem B. 2016 Jul 7;120(26):6120-9. doi: 10.1021/acs.jpcb.6b02163. Epub 2016 Apr 13.
9
Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.全身给药的树枝状大分子在脑肿瘤中的均匀分布及对肿瘤相关巨噬细胞的靶向作用。
Biomaterials. 2015 Jun;52:507-16. doi: 10.1016/j.biomaterials.2015.02.053. Epub 2015 Mar 18.
10
Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.胶质母细胞瘤和间变性星形细胞瘤中 HIF-1 的差异表达。
Int J Oncol. 2012 Oct;41(4):1260-70. doi: 10.3892/ijo.2012.1555. Epub 2012 Jul 16.